These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22798327)

  • 21. Intra-arterial therapy for acute ischemic stroke under general anesthesia versus monitored anesthesia care.
    John S; Thebo U; Gomes J; Saqqur M; Farag E; Xu J; Wisco D; Uchino K; Hussain MS
    Cerebrovasc Dis; 2014; 38(4):262-7. PubMed ID: 25401730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does modern ischemic stroke therapy in a large community-based dedicated stroke center improve clinical outcomes? A two-year retrospective study.
    Berlet MH; Stambo GW; Kelley M; Van Epps K; Woeste T; Steffen D
    J Stroke Cerebrovasc Dis; 2014; 23(5):869-78. PubMed ID: 24011839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of endovascular thrombectomy with and without bridging thrombolysis for acute large vessel occlusion ischaemic stroke.
    Maingard J; Shvarts Y; Motyer R; Thijs V; Brennan P; O'Hare A; Looby S; Thornton J; Hirsch JA; Barras CD; Chandra RV; Brooks M; Asadi H; Kok HK
    Intern Med J; 2019 Mar; 49(3):345-351. PubMed ID: 30091271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variability in the use of intravenous thrombolysis for mild stroke: experience across the SPOTRIAS network.
    Willey JZ; Khatri P; Khoury JC; Merino JG; Ford AL; Rost NS; Gonzales NR; Ali LK; Meyer BC; Broderick JP
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):318-22. PubMed ID: 22177935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selecting endovascular treatment strategy according to the location of intracranial occlusion in acute stroke.
    Pagola J; Rubiera M; Flores A; Rodríguez-Luna D; Piñeiro S; Muchada MA; Quintana M; Alvarez-Sabin J; Molina CA; Ribo M
    Cerebrovasc Dis; 2013; 35(6):502-6. PubMed ID: 23751728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intra-arterial thrombectomy versus standard intravenous thrombolysis in patients with anterior circulation stroke caused by intracranial arterial occlusions: a single-center experience.
    Sallustio F; Koch G; Di Legge S; Rossi C; Rizzato B; Napolitano S; Samà D; Arnò N; Giordano A; Tropepi D; Misaggi G; Diomedi M; Del Giudice C; Spinelli A; Fabiano S; Stefanini M; Konda D; Reale CA; Pampana E; Simonetti G; Stanzione P; Gandini R
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e323-31. PubMed ID: 23379980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients with Thrombocytopenia.
    Yang Y; Liu B; Wu L; Guan X; Luo Y; Jiang C; Gupta S; Huang Z; Everett G
    Cerebrovasc Dis; 2019; 48(3-6):157-164. PubMed ID: 31694030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?
    Shaltoni HM; Albright KC; Gonzales NR; Weir RU; Khaja AM; Sugg RM; Campbell MS; Cacayorin ED; Grotta JC; Noser EA
    Stroke; 2007 Jan; 38(1):80-4. PubMed ID: 17122433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombolytic therapy in ischemic stroke patients with pre-stroke depression in the telestroke vs non-telestroke.
    Moraney R; Poupore N; Shugart R; Tate M; Snell A; Brown K; Nathaniel TI
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):104890. PubMed ID: 32807408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prior Asymptomatic Parenchymal Hemorrhage Does Not Increase the Risk for Intracranial Hemorrhage after Intravenous Thrombolysis.
    AbdelRazek MA; Mowla A; Hojnacki D; Zimmer W; Elsadek R; Abdelhamid N; Elsadek L; Farooq S; Kamal H; Crumlish A; Shirani P; Ching M; Sawyer R
    Cerebrovasc Dis; 2015; 40(5-6):201-4. PubMed ID: 26402147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bridging intravenous-intra-arterial rescue strategy increases recanalization and the likelihood of a good outcome in nonresponder intravenous tissue plasminogen activator-treated patients: a case-control study.
    Rubiera M; Ribo M; Pagola J; Coscojuela P; Rodriguez-Luna D; Maisterra O; Ibarra B; Piñeiro S; Meler P; Romero FJ; Alvarez-Sabin J; Molina CA
    Stroke; 2011 Apr; 42(4):993-7. PubMed ID: 21372307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry.
    Romano JG; Smith EE; Liang L; Gardener H; Camp S; Shuey L; Cook A; Campo-Bustillo I; Khatri P; Bhatt DL; Fonarow GC; Sacco RL; Schwamm LH
    JAMA Neurol; 2015 Apr; 72(4):423-31. PubMed ID: 25642650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining mild stroke: outcomes analysis of treated and untreated mild stroke patients.
    Spokoyny I; Raman R; Ernstrom K; Khatri P; Meyer DM; Hemmen TM; Meyer BC
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1276-81. PubMed ID: 25906938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of full-dose intravenous recombinant tissue plasminogen activator followed by multimodal endovascular therapy for acute ischemic stroke.
    Nogueira RG; Yoo AJ; Masrur S; Batista LM; Hakimelahi R; Hirsch JA; Schwamm LH
    J Neurointerv Surg; 2013 Jul; 5(4):298-301. PubMed ID: 22705875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early Endovascular Treatment in Intravenous Tissue Plasminogen Activator-Ineligible Patients.
    Rebello LC; Haussen DC; Grossberg JA; Belagaje S; Lima A; Anderson A; Frankel MR; Nogueira RG
    Stroke; 2016 Apr; 47(4):1131-4. PubMed ID: 26906918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional outcome after primary endovascular therapy or IV thrombolysis alone for stroke. An observational, comparative effectiveness study.
    Abilleira S; Ribera A; Dávalos A; Ribó M; Chamorro A; Cardona P; Molina CA; Martínez-Yélamos A; Urra X; Dorado L; Roquer J; Martí-Fàbregas J; Aja L; Tomasello A; Castaño C; Blasco J; Cánovas D; Castellanos M; Krupinski J; Guimaraens L; Perendreu J; Ustrell X; Purroy F; Gómez-Choco M; Baiges JJ; Cocho D; Saura J; Gallofré M;
    Cerebrovasc Dis; 2014; 38(5):328-36. PubMed ID: 25428822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke?
    Agarwal P; Kumar S; Hariharan S; Eshkar N; Verro P; Cohen B; Sen S
    Cerebrovasc Dis; 2004; 17(2-3):182-90. PubMed ID: 14707420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age ≥80 Years Is Not a Contraindication for Intra-Arterial Therapy after Ischemic Stroke.
    Leonard J; Frei D; Salottolo K; Fanale CV; Wagner JC; Whaley M; McCarthy K; Bellon RJ; Loy D; Bar-Or D
    Cerebrovasc Dis; 2015; 40(3-4):121-8. PubMed ID: 26202214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign.
    Mattle HP; Arnold M; Georgiadis D; Baumann C; Nedeltchev K; Benninger D; Remonda L; von Büdingen C; Diana A; Pangalu A; Schroth G; Baumgartner RW
    Stroke; 2008 Feb; 39(2):379-83. PubMed ID: 18096842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.